LUIS ZARAZUA: Open Payments
NPI 1326628736 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 16 payments from 11 companies in 2025. Trend: 2023 $360 · 2024 $383 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $189 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $42 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
| ARGENX US, INC. | 1 | $28 |
| ABBVIE INC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: REPATHA, JOURNAVX, OTEZLA, MOUNJARO, Cologuard Collection Kit, AIRSUPRA, VYVGART HYTRULO, QULIPTA.
Industry payments across CA — which companies pay providers there.
